In SAMP8 mice (sporadic AD model), we evaluated the effects of pharmacological inhibition of G9a (UNC0642), combined with CB1R agonism (ACEA) and/or CB2R agonism (JWH133), on cognitive recovery, neuronal morphology, and neuroinflammation. This evidence concerns the gene CNR1 and Alzheimer disease.